BIO-RAD LABORATORIES, INC. files 10-Q

Bio-Rad Laboratories reported a net loss of $527.1 million for the first quarter of 2026, a significant decrease from a net income of $64.0 million in the same period last year, largely due to a substantial unrealized loss on its investment in Sartorius AG. The company's net sales increased slightly to $592.1 million, but on a currency-neutral basis, sales decreased, impacted by geopolitical events and market challenges.